Exane BNP Paribas Initiates Coverage On Healthpeak Properties with Underperform Rating, Announces Price Target of $18
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas analyst Nate Crossett has initiated coverage on Healthpeak Properties (NYSE:PEAK) with an Underperform rating and a price target of $18.
October 11, 2023 | 4:50 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Healthpeak Properties has been given an Underperform rating by Exane BNP Paribas, with a price target of $18.
The Underperform rating given by Exane BNP Paribas suggests that the analyst believes Healthpeak Properties' stock will do worse than the market average. This could potentially lead to a decrease in the stock's price. The price target of $18 also provides a specific value expectation for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100